Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing. Giving more than one
drug (combination chemotherapy) may kill more cancer cells. It is not yet known which
combination chemotherapy regimen is more effective in treating young patients with acute
lymphoblastic leukemia.
PURPOSE: Thisphase III trial is studying several different combination chemotherapy regimens
to compare how well they work in treating young patients with acute lymphoblastic leukemia.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital Schleswig-Holstein University of Schleswig-Holstein